These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 30672673)

  • 1. [The possibility of applying historical concentration of thrombocytes in examination of donors.].
    Ayupova RF; Sultanbaiev US; Zhiburt EB
    Klin Lab Diagn; 2018; 63(2):95-98. PubMed ID: 30672673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of historical platelet counts from blood donors to program apheresis platelet donation: An Australian perspective.
    Hirani R; Peberdy J; Mondy P
    Transfus Apher Sci; 2018 Apr; 57(2):239-242. PubMed ID: 29530405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matching blood donations to type-specific product needs: a recruitment technique.
    Kuriyan M; Wells S
    J Clin Apher; 1995; 10(1):23-6. PubMed ID: 7601863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
    Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
    Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of pre-donation pulse assessment for apheresis donors.
    Page EA; Harrison JF
    Transfus Med; 2012 Feb; 22(1):52-6. PubMed ID: 22132749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of donor apheresis.
    Winters JL
    J Clin Apher; 2006 Jul; 21(2):132-41. PubMed ID: 15880355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasovagal reactions in whole blood and apheresis donors: a cross-sectional study on donor haemovigilance data from 2016 to 2019 in Italy.
    Piccinini V; Marano G; Catalano L; Pati I; Veropalumbo E; de Waure C; Pupella S; De Angelis V
    Blood Transfus; 2022 Jul; 20(4):281-291. PubMed ID: 34694220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of repeat apheresis donors in Japan.
    Furuta M; Shimizu T; Mizuno S; Kamiya T; Ozawa K; Nakase T; Tadokoro K; Takenaka M; Ohkawa T; Yokoyama S; Ogawa Y; Kiyokawa H; Shimizu M; Sekine N; Yoshimura I
    Vox Sang; 1999; 77(1):17-23. PubMed ID: 10474086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell collection by apheresis technology.
    Meyer D; Bolgiano DC; Sayers M; Price T; Benson D; Slichter SJ
    Transfusion; 1993 Oct; 33(10):819-24. PubMed ID: 8236422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events and retention of donors of double red cell units by apheresis.
    Keshelashvili K; O'meara A; Stern M; Jirout Z; Pehlic V; Holbro A; Buser A; Sigle J; Infanti L
    Blood Transfus; 2016 Sep; 14(5):391-9. PubMed ID: 27136442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ferritin estimation in blood donors subject to apheresis on IBM 2997 cell separator.
    Sebestík V; Sejkorová J; Fiala J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):776-82. PubMed ID: 2436990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the mean platelet volume MPV for the quality assessment of apheresis procedures.
    Bramhoff A; Giers G; Blessing F; Wenzel F
    Clin Hemorheol Microcirc; 2016; 64(3):413-424. PubMed ID: 28128757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apheresis donors and platelet function: inherent platelet responsiveness influences platelet quality.
    Garner SF; Jones CI; Stephens J; Burns P; Walton J; Bernard A; Angenent W; Ouwehand WH; Goodall AH;
    Transfusion; 2008 Apr; 48(4):673-80. PubMed ID: 18194381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Namibia's transition from whole blood-derived pooled platelets to single-donor apheresis platelet collections.
    Pitman JP; Basavaraju SV; Shiraishi RW; Wilkinson R; von Finckenstein B; Lowrance DW; Marfin AA; Postma M; Mataranyika M; Smit Sibinga CT
    Transfusion; 2015 Jul; 55(7):1685-92. PubMed ID: 25727921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of apheresis donation.
    Sniecinski IJ
    Infusionsther Klin Ernahr; 1987 Sep; 14 Suppl 4():52-6. PubMed ID: 3679530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.